Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;40(6):527-537.
doi: 10.3393/ac.2024.00745.0106. Epub 2024 Dec 20.

Beyond survival: a comprehensive review of quality of life in rectal cancer patients

Affiliations
Review

Beyond survival: a comprehensive review of quality of life in rectal cancer patients

Won Beom Jung. Ann Coloproctol. 2024 Dec.

Abstract

Rectal cancer is one of the most common carcinomas and a leading cause of cancer-related mortality. Although significant advancements have been made in the treatment of rectal cancer, the deterioration of quality of life (QoL) remains a challenging issue. Various tools have been developed to assess QoL, including the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) scale, the QLQ-C30 and QLQ-CR29 by the European Organization for Research and Treatment of Cancer (EORTC), and the 36-Item Short Form Health Survey (SF-36). Factors such as the lower location of the tumor, radiation therapy, chemoradiotherapy, and chemotherapy are associated with a decline in QoL. Furthermore, anastomotic leakage following rectal cancer resection is an important risk factor affecting QoL. With the development of novel treatment approaches, including neoadjuvant therapies such as chemoradiotherapy and total neoadjuvant therapy, the rate of clinical complete remission has increased, leading to the emergence of organ-preserving strategies. Both local excision and the "watch-and-wait" approach following neoadjuvant therapy improved functional outcomes and QoL. Efforts to improve QoL after rectal cancer surgery are ongoing in surgical techniques for rectal cancer. Since QoL is determined by a complex interplay of factors, including the patient's physical condition, surgical techniques, and psychological and social elements, a comprehensive approach is necessary to understand and enhance it. This review aims to describe the methods for measuring QoL in rectal cancer patients after surgery, the key risk factors involved, and various strategies and efforts to improve QoL outcomes.

Keywords: Chemoradiotherapy; Low anterior resection syndrome; Quality of life; Rectal neoplasms.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Won Beom Jung is an Editorial Board member of Annals of Coloproctology, but was not involved in the reviewing or decision process of this manuscript. No other potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Factors related with quality of life (QoL) after rectal cancer surgery. Multiple patient-related, disease-specific, and surgery-related factors involve in determining QoL. APR, abdominoperineal resection; SPR, sphincter-preserving resection.

Similar articles

Cited by

References

    1. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233–54. doi: 10.3322/caac.21772. - DOI - PubMed
    1. Park EH, Jung KW, Park NJ, Kang MJ, Yun EH, Kim HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2021. Cancer Res Treat. 2024;56:357–71. doi: 10.4143/crt.2024.253. - DOI - PMC - PubMed
    1. Kim MH, Park S, Yi N, Kang B, Park IJ. Colorectal cancer mortality trends in the era of cancer survivorship in Korea: 2000–2020. Ann Coloproctol. 2022;38:343–52. doi: 10.3393/ac.2022.00535.0076. - DOI - PMC - PubMed
    1. Sychev S, Ponomarenko A, Chernyshov S, Alekseev M, Mamedli Z, Kuzmichev D, et al. Total neoadjuvant therapy in rectal cancer: a network meta-analysis of randomized trials. Ann Coloproctol. 2023;39:289–300. doi: 10.3393/ac.2022.00920.0131. - DOI - PMC - PubMed
    1. Neary E, Ibrahim T, Verschoor CP, Zhang L, Patel SV, Chadi SA, et al. A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer. Colorectal Dis. 2024;26:837–50. doi: 10.1111/codi.16982. - DOI - PubMed

LinkOut - more resources